While Astrazeneca News Today

GSKs annual vaccine sales surged by 25%, driven by Shingrix and Arexvy. Cancer drugs also performed strongly.

The FDA will decide this summer which strains the next Covid-19 vaccines should address. But companies are also taking a longer view, developing shots for the future that offer different features than the current ones and potentially broader protection against a wider range of pathogens.

Among the companies with reports and trading updates today are Unilever, British American Tobacco, AstraZeneca, Bellway, Compass Group and Redrow.

The first authorized drugs and vaccines indicated for COVID-19 generated more than a combined $10.91 billion in sales during the first quarter of 2021—more than double the $4.23 billion generated all of 2020. This list contains the Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021

But while all the seven vaccines boosted spike protein immunogenicity after two doses of AstraZeneca, in case of Pfizer, after two doses, a booster dose of Valneva was not found to be effective.

 The CDC declared on October 18 that a person should be deemed completely immunised against COVID-19 even if they received 2 different sets of vaccinations.

Here we tell you the risk factors that influence infection in immunized people, also known as infection in vaccinated

The first authorized drugs and vaccines indicated for COVID-19 generated more than a combined $10.91 billion in sales during the first quarter of 2021—more than double the $4.23 billion generated all of 2020. This list contains the Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021

© Sherborne Investors Edward Bramson’s Sherborne Investors has finally called time on its campaign against Barclays. In 2018, the activist investor built up a 6% stake in the bank, and used that shareholding to campaign for the removal of the chief executive, and a shake-up of its management and strategy. Not many other investors got on board, however. Last week, he finally called it a day. But if Bramson wants to move on to another company, he won’t be short of targets. Quite a few other ...

Apr 09, 2021, 15:39 IST By M Somasekhar When Hyderabad-based Pharma major, Dr Reddy’s announced that it was partnering the RIDF, Moscow to undertake clinical trials and distribute the Sputnik V vaccine in India in the September 2020, as the global pandemic was spreading fast, it raised both public and market interest.  In March 2021, Dr Reddy’s says, its just weeks before the Vaccine could get clearance from Indian regulators for use. In the meantime, atleast half a dozen Indian dru...